[go: up one dir, main page]

MXPA02008110A - Liposomas terapeuticos radioactivos. - Google Patents

Liposomas terapeuticos radioactivos.

Info

Publication number
MXPA02008110A
MXPA02008110A MXPA02008110A MXPA02008110A MXPA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A
Authority
MX
Mexico
Prior art keywords
liposomes
radioactive therapeutic
therapeutic liposomes
radioactive
ionophores
Prior art date
Application number
MXPA02008110A
Other languages
English (en)
Inventor
Roy H Larsen
Original Assignee
Anticancer Therapeutic Inv Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anticancer Therapeutic Inv Sa filed Critical Anticancer Therapeutic Inv Sa
Publication of MXPA02008110A publication Critical patent/MXPA02008110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA02008110A 2000-02-21 2001-02-21 Liposomas terapeuticos radioactivos. MXPA02008110A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20000855A NO312708B1 (no) 2000-02-21 2000-02-21 Radioaktive liposomer til terapi
PCT/NO2001/000065 WO2001060417A2 (en) 2000-02-21 2001-02-21 Radioactive therapeutic liposomes

Publications (1)

Publication Number Publication Date
MXPA02008110A true MXPA02008110A (es) 2003-12-11

Family

ID=19910768

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02008110A MXPA02008110A (es) 2000-02-21 2001-02-21 Liposomas terapeuticos radioactivos.

Country Status (21)

Country Link
US (1) US6592843B2 (es)
EP (1) EP1257299B9 (es)
JP (1) JP4933712B2 (es)
KR (1) KR100822566B1 (es)
CN (1) CN100350981C (es)
AT (1) ATE300316T1 (es)
AU (2) AU3782701A (es)
BR (1) BR0108572A (es)
CA (1) CA2400994C (es)
CZ (1) CZ299032B6 (es)
DE (1) DE60112251T2 (es)
DK (1) DK1257299T3 (es)
EA (1) EA005624B1 (es)
ES (1) ES2247069T3 (es)
MX (1) MXPA02008110A (es)
NO (1) NO312708B1 (es)
NZ (1) NZ520848A (es)
PL (1) PL201398B1 (es)
UA (1) UA73160C2 (es)
WO (1) WO2001060417A2 (es)
ZA (1) ZA200206500B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
US8029795B2 (en) * 1999-12-30 2011-10-04 Gwathmey, Inc. Targeted iron chelator delivery system
US20040166060A1 (en) * 2000-06-16 2004-08-26 Sloan Kettering Institute For Cancer Research Liposomal encapsulation of alpha particle emittors and uses thereof
DE60135743D1 (de) * 2000-06-16 2008-10-23 Sloan Kettering Inst Cancer Liposomale einkapselung von alphastrahlern, und deren verwendung
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
GB0213261D0 (en) * 2002-06-10 2002-07-17 Anticancer Therapeutic Inv Sa Method
AU2004229218B2 (en) * 2003-04-15 2009-05-07 Algeta As Thorium-227 for use in radiotherapy of soft tissue disease
GB0308731D0 (en) * 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
CA2536393A1 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
BRPI0507824A (pt) * 2004-02-20 2007-07-10 Algeta As hidroxiapatita, processo para a preparação de um particulado de hidroxiapatita marcada com radionuclìdeo, composição farmacêutica, uso de hidroxiapatita e de um radionuclìdeo emissor de alfa ou um radionuclìdeo emissor de beta, dispositivo, e, método de tratamento radioquìmico de um ser humano ou de um indivìduo animal não humano necessitando do mesmo
EP1722762A2 (en) * 2004-03-02 2006-11-22 Massachusetts Institute of Technology Nanocell drug delivery system
US20070053845A1 (en) * 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
GB0423565D0 (en) * 2004-10-22 2004-11-24 Algeta As Formulation
EP1861072A2 (en) * 2005-03-14 2007-12-05 Massachusetts Institute Of Technology Nanocells for diagnosis and treatment of diseases and disorders
US8709380B1 (en) * 2006-02-07 2014-04-29 Sirius Medicine, Llc Targeting agents for enhancing radiation therapy
US20070224115A1 (en) * 2006-03-22 2007-09-27 The Regents Of The University Of California Polymeric chelators for radionuclide delivery systems
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
US20100178244A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
AU2010272957B2 (en) * 2009-07-17 2016-03-03 Rigshospitalet Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
JP2011111438A (ja) * 2009-11-30 2011-06-09 Akita Univ 有機金属錯体を有効成分として含有する抗がん剤
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
CA2821024A1 (en) * 2010-12-14 2012-06-21 Technical University Of Denmark Entrapment of radionuclides in nanoparticle compositions
GB201105298D0 (en) * 2011-03-29 2011-05-11 Algeta Asa Pharmaceutical preparation
DE102011079031A1 (de) * 2011-07-12 2013-01-17 Algeta Asa Flüssigkeitsbehälter
GB201208309D0 (en) 2012-05-11 2012-06-27 Algeta As Complexes
US20160022842A1 (en) * 2013-03-11 2016-01-28 Wayne State University Formation and uses of europium
MX369632B (es) * 2015-02-26 2019-11-14 Sciencons AS Soluciones radiofarmaceuticas con propiedades ventajosas.
NO3061464T3 (es) * 2015-02-26 2018-03-24
US9433690B1 (en) * 2015-02-26 2016-09-06 Sciencons AS Radiopharmaceutical solutions with advantageous properties
DK3111959T3 (en) * 2015-07-03 2018-01-02 Oncoinvent As Radiopharmaceutical particles and suspensions
MX2018011629A (es) 2016-03-24 2019-03-14 Bayer Pharma AG Complejos radiofarmaceuticos.
EA201892814A1 (ru) 2016-06-10 2019-06-28 Байер Фарма Акциенгезельшафт Радиофармацевтические комплексы
PL3474904T3 (pl) * 2016-06-24 2024-12-16 Sciencons AS Otrzymywanie przeciwciał monoklonalnych znakowanych 212pb
SG11201910176PA (en) 2017-05-11 2019-11-28 Alpha Tau Medical Ltd Polymer coatings for brachytherapy devices
CN111918699B (zh) 2018-04-02 2024-03-08 阿尔法陶医疗有限公司 放射性核素的受控释放的装置
EP4003959A1 (en) 2019-07-25 2022-06-01 Bayer AS Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer
MX2022006638A (es) 2019-12-05 2022-07-19 Sciencons AS Producción de 212pb altamente purificados.
CA3202211A1 (en) 2020-12-16 2022-06-23 Alpha Tau Medical Ltd. Diffusing alpha-emitters radiation therapy with enhanced beta treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025240A2 (en) * 1992-06-09 1993-12-23 Neorx Corporation Pretargeting methods and compounds
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
CA1298548C (en) * 1984-10-22 1992-04-07 Cary Arnet Presant Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
DE3880691T2 (de) * 1987-11-04 1993-08-12 Vestar Inc Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren.
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
ES2299256T3 (es) * 1998-05-26 2008-05-16 Sloan-Kettering Institute For Cancer Research Constructos que emiten particulas alfa y sus usos.

Also Published As

Publication number Publication date
WO2001060417A2 (en) 2001-08-23
DK1257299T3 (da) 2005-11-21
US20010048914A1 (en) 2001-12-06
PL358541A1 (en) 2004-08-09
DE60112251D1 (de) 2005-09-01
ZA200206500B (en) 2003-08-14
ES2247069T3 (es) 2006-03-01
KR100822566B1 (ko) 2008-04-16
CN1404402A (zh) 2003-03-19
EP1257299B1 (en) 2005-07-27
EP1257299A2 (en) 2002-11-20
NO20000855D0 (no) 2000-02-21
US6592843B2 (en) 2003-07-15
EA200200793A1 (ru) 2003-02-27
CA2400994A1 (en) 2001-08-23
NZ520848A (en) 2005-02-25
NO20000855L (no) 2001-08-22
AU2001237827B2 (en) 2007-11-22
EA005624B1 (ru) 2005-04-28
AU3782701A (en) 2001-08-27
AU2001237827B8 (en) 2001-08-27
CA2400994C (en) 2009-07-07
JP2003522808A (ja) 2003-07-29
UA73160C2 (uk) 2005-06-15
PL201398B1 (pl) 2009-04-30
DE60112251T2 (de) 2006-03-30
EP1257299B9 (en) 2005-11-30
CN100350981C (zh) 2007-11-28
ATE300316T1 (de) 2005-08-15
CZ299032B6 (cs) 2008-04-09
NO312708B1 (no) 2002-06-24
JP4933712B2 (ja) 2012-05-16
WO2001060417A3 (en) 2002-02-07
BR0108572A (pt) 2002-11-19
KR20020092963A (ko) 2002-12-12
CZ20023164A3 (cs) 2003-04-16

Similar Documents

Publication Publication Date Title
AU3782701A (en) Radioactive therapeutic liposomes
GB0105772D0 (en) Use
MXPA04009163A (es) Nuevos compuestos.
IL161187A0 (en) Liposome compositions containing metal ions and therapeutic agents
EP1242106A4 (en) IMPROVING INHALATION THERAPY USING CARBON GAS
BR0114316A (pt) Processo para a preparação de formulações em pó
NZ522368A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
TR200200263T2 (tr) Yeni seçiçi retinoid agonistleri
IL152348A0 (en) Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
MY121523A (en) Resorcinol derivatives
IL150367A0 (en) Method for the preparation of citalopram
MY137580A (en) Radioactive therapeutic liposomes
ZA200303045B (en) Inhalable formulation of a solution containing a tiotropium salt.
GB2342352A (en) Tramadol salts thereof and process for their preparation
NZ507407A (en) Stable mitoxantrone solutions
AP1413A (en) Rescorcinol composition.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
YU112585A (en) Process for obtaining l-norcarnitine hydro-chloride
UA30266A (uk) Протихламідійний фітозасіб
UA30267A (uk) Протирикетсійний фітозасіб
IT1313683B1 (it) Procedimento per la preparazione di marbofloxacina.
UA29276A (uk) Спосіб моделювання системного аутоімунного захворювання

Legal Events

Date Code Title Description
FG Grant or registration